Shopping Cart 0
Cart Subtotal
AED 0

Recipharm AB (RECI B) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Recipharm AB (RECI B)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, and development and technology services. The company's manufacturing segment provides contract manufacturing of pharmaceuticals such as semi-solids, and oral liquids, solid dose, sterile products, besides clinical trial materials including APIs and other drugs. Recipharm's development and technology segment offers raw material supply, formulation development and development of validated analytical methods, among others. The company operates in the UK, Germany, Spain, Italy, Sweden, France, and others. Recipharm is headquartered in Stockholm, Sweden.

Recipharm AB Key Recent Developments

Feb 28,2019 Recipharm achieves new ISO 45001 certification to support sustainability efforts

Feb 21,2019 Recipharm publishes its report for the fourth quarter and full year 2018

Feb 14,2019 Recipharm announces all its facilities are ready for EU serialisation

Feb 12,2019 Recipharm names new Director of Business Management

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Recipharm AB-Key Facts

Recipharm AB-Key Employees

Recipharm AB-Key Employee Biographies

Recipharm AB-Major Products and Services

Recipharm AB-History

Recipharm AB-Company Statement

Recipharm AB-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview

Recipharm AB-Business Description

Business Segment: D&T

Overview

Performance

Business Segment: MFG-SL

Overview

Performance

Business Segment: MFG-SO

Overview

Performance

Geographical Segment: France

Performance

Geographical Segment: Germany

Performance

Geographical Segment: India

Performance

Geographical Segment: Italy

Performance

Geographical Segment: Other

Performance

Geographical Segment: Portugal

Performance

Geographical Segment: Spain

Performance

Geographical Segment: Sweden

Performance

Recipharm AB-Corporate Strategy

Recipharm AB-SWOT Analysis

SWOT Analysis-Overview

Recipharm AB-Strengths

Recipharm AB-Weaknesses

Recipharm AB-Opportunities

Recipharm AB-Threats

Recipharm AB-Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4 - Company's Lifesciences Financial Deals and Alliances

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Recipharm AB, Recent Deals Summary

Section 5 - Company's Recent Developments

Feb 28, 2019: Recipharm achieves new ISO 45001 certification to support sustainability efforts

Feb 21, 2019: Recipharm publishes its report for the fourth quarter and full year 2018

Feb 14, 2019: Recipharm announces all its facilities are ready for EU serialisation

Feb 12, 2019: Recipharm names new Director of Business Management

Dec 19, 2018: Recipharm to potentially end operations in Ashton-under-Lyne facility

Nov 08, 2018: Recipharm publishes its interim report January-September 2018

Oct 25, 2018: Manufacturing licence restriction at Recipharm, Ashton-u-Lyne, UK facility

Oct 19, 2018: Recipharm continues manufacturing operations in Hoganas, Sweden

Oct 09, 2018: Recipharm releases first serialised products to Europe

Oct 03, 2018: Recipharm names Tobias Hagglov as Chief Financial Officer

Section 6 - Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Recipharm AB, Performance Chart (2014-2018)

Recipharm AB, Ratio Charts

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Recipharm AB, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Recipharm AB, Key Facts

Recipharm AB, Key Employees

Recipharm AB, Key Employee Biographies

Recipharm AB, Major Products and Services

Recipharm AB, History

Recipharm AB, Other Locations

Recipharm AB, Subsidiaries

Recipharm AB, Key Competitors

Recipharm AB, Ratios based on current share price

Recipharm AB, Annual Ratios

Recipharm AB, Annual Ratios (Cont...1)

Recipharm AB, Annual Ratios (Cont...2)

Recipharm AB, Interim Ratios

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Recipharm AB, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Vetter Pharma-Fertigung GmbH & Co KG

Iconovo AB

Fareva SA

Famar Health Care Services

F. Hoffmann-La Roche Ltd

Corden Pharma International GmbH

Boehringer Ingelheim GmbH

Company Profile

Company Profile Title

Recipharm AB (RECI B)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, and development and technology services. The company's manufacturing segment provides contract manufacturing of pharmaceuticals such as semi-solids, and oral liquids, solid dose, sterile products, besides clinical trial materials including APIs and other drugs. Recipharm's development and technology segment offers raw material supply, formulation development and development of validated analytical methods, among others. The company operates in the UK, Germany, Spain, Italy, Sweden, France, and others. Recipharm is headquartered in Stockholm, Sweden.

Recipharm AB Key Recent Developments

Feb 28,2019 Recipharm achieves new ISO 45001 certification to support sustainability efforts

Feb 21,2019 Recipharm publishes its report for the fourth quarter and full year 2018

Feb 14,2019 Recipharm announces all its facilities are ready for EU serialisation

Feb 12,2019 Recipharm names new Director of Business Management

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Recipharm AB-Key Facts

Recipharm AB-Key Employees

Recipharm AB-Key Employee Biographies

Recipharm AB-Major Products and Services

Recipharm AB-History

Recipharm AB-Company Statement

Recipharm AB-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview

Recipharm AB-Business Description

Business Segment: D&T

Overview

Performance

Business Segment: MFG-SL

Overview

Performance

Business Segment: MFG-SO

Overview

Performance

Geographical Segment: France

Performance

Geographical Segment: Germany

Performance

Geographical Segment: India

Performance

Geographical Segment: Italy

Performance

Geographical Segment: Other

Performance

Geographical Segment: Portugal

Performance

Geographical Segment: Spain

Performance

Geographical Segment: Sweden

Performance

Recipharm AB-Corporate Strategy

Recipharm AB-SWOT Analysis

SWOT Analysis-Overview

Recipharm AB-Strengths

Recipharm AB-Weaknesses

Recipharm AB-Opportunities

Recipharm AB-Threats

Recipharm AB-Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4 - Company's Lifesciences Financial Deals and Alliances

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Recipharm AB, Recent Deals Summary

Section 5 - Company's Recent Developments

Feb 28, 2019: Recipharm achieves new ISO 45001 certification to support sustainability efforts

Feb 21, 2019: Recipharm publishes its report for the fourth quarter and full year 2018

Feb 14, 2019: Recipharm announces all its facilities are ready for EU serialisation

Feb 12, 2019: Recipharm names new Director of Business Management

Dec 19, 2018: Recipharm to potentially end operations in Ashton-under-Lyne facility

Nov 08, 2018: Recipharm publishes its interim report January-September 2018

Oct 25, 2018: Manufacturing licence restriction at Recipharm, Ashton-u-Lyne, UK facility

Oct 19, 2018: Recipharm continues manufacturing operations in Hoganas, Sweden

Oct 09, 2018: Recipharm releases first serialised products to Europe

Oct 03, 2018: Recipharm names Tobias Hagglov as Chief Financial Officer

Section 6 - Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Recipharm AB, Performance Chart (2014-2018)

Recipharm AB, Ratio Charts

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Recipharm AB, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Recipharm AB, Key Facts

Recipharm AB, Key Employees

Recipharm AB, Key Employee Biographies

Recipharm AB, Major Products and Services

Recipharm AB, History

Recipharm AB, Other Locations

Recipharm AB, Subsidiaries

Recipharm AB, Key Competitors

Recipharm AB, Ratios based on current share price

Recipharm AB, Annual Ratios

Recipharm AB, Annual Ratios (Cont...1)

Recipharm AB, Annual Ratios (Cont...2)

Recipharm AB, Interim Ratios

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Recipharm AB, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Vetter Pharma-Fertigung GmbH & Co KG

Iconovo AB

Fareva SA

Famar Health Care Services

F. Hoffmann-La Roche Ltd

Corden Pharma International GmbH

Boehringer Ingelheim GmbH